CD4 and tuberculosis: Based on recent evidence from a randomized trial (8), WHO recommends that the lateral flow urine lipoarabinomannan assay may be used to assist in the rapid diagnosis and treatment of disseminated TB among persons living with HIV admitted to hospital with CD4 <100/μL and symptoms of TB.